Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Physicians offer new solution for blood transfusions

12.11.2002


The successful transfusion of a cell-free blood product on a 14-year-old Jehovah’s Witness may offer a solution for patients opposed to blood transfusions due to religious or personal beliefs.



"This was the first successful use of a human cell-free hemoglobin solution in a pediatric patient to manage life-threatening anemia due to an autoimmune disease," says Dr. Brian Kavanagh, professor of medicine at the University of Toronto and staff physician in critical care medicine at The Hospital for Sick Children. The patient suffered from immune thrombocytopenia, a condition that attacks platelets in the body. Platelets are present in blood and help blood clot; if platelet counts are very low, minor injuries or trauma can become very serious if the patient continues to bleed.

Kavanagh and colleagues Drs. Johann Hitzler and Natalie Anton treated the patient last year after she entered the hospital’s emergency room for a nosebleed that did not stop. Instead of a blood transfusion, they used a biochemically manufactured solution that contains hemoglobin but does not contain red blood cells. The solution has been used in adults but never for a child in this kind of situation, Kavanagh says.


While more study needs to be done with pediatric patients, Kavanagh says this cell-free hemoglobin is a viable alternative for Jehovah’s Witnesses. "Most current blood replacement options are fluids, plasma and other types of liquids that provide volume for blood but don’t provide the oxygen-carrying capacity. This solution provides oxygen-carrying capacity in exactly the same way that blood cells in hemoglobin do. That’s the crux of the matter. Still, only careful study will fully determine the balance of benefits and risk."

Kavanagh and colleagues reported this case in a fall issue of the British Journal of Haematology.


CONTACT: Dr. Brian Kavanagh of medicine at U of T and The Hospital for Sick Children, 416-813-6860, brian.kavanagh@sickkids.ca
or Janet Wong, U of T public affairs, 416-978-5949, jf.wong@utoronto.ca


Janet Wong | EurekAlert!
Further information:
http://www.utoronto.ca/

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>